Product Recalls in Rhode Island

Product recalls affecting Rhode Island — including food, drugs, consumer products, medical devices, and vehicles distributed to Rhode Island. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,521 recalls have been distributed to Rhode Island in the last 12 months.

47,970 total recalls
2,521 in last 12 months

Showing 90619080 of 47,970 recalls

DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Sodium Chloride Ophthalmic Ointment Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Azelastine Hydrochloride Nasal Spray Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Levocarnitine Oral Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ciclopirox Topical Solution 8% (Nail Lacquer) Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Artificial Tears Ointment Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lidocaine 2.5% & Prilocaine 2.5% Cream Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Megestrol Acetate Oral Suspension Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ferrous Sulfate Iron Supplement Drops Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Artificial Tears Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Clobetasol Propionate Ointment Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Rifampin Capsules USP Recalled by Akorn, Inc. Due to CGMP Deviations: Firm...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ephedrine Sulfate Injection Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ropivacaine Hydrochloride Injection USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Atropine Sulfate Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: AK-POLY-BAC (bacitracin Zinc and Polymyxin B Sulfate) Ophthalmic Ointment...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lorazepam Injection Recalled by Akorn, Inc. Due to CGMP Deviations: Firm...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Naloxone Injection Recalled by Akorn, Inc. Due to CGMP Deviations: Firm went...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Cromolyn Sodium Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: IC-Green (indocyanine green for injection Recalled by Akorn, Inc. Due to...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund